FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/03/2024
Voltar para busca
Dado oficial do USPTO
MNEMO JETS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MNEMO JETS
ST13
US500000079345490Classe
1, 5, 40, 42, 44
Pedido
79345490
Registro
7220558
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
18/03/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42, 44
Data de depósito
13/01/2022
Data de registro
21/11/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/11/2023
Última transação
21/11/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
34
Localização do titular
FR
Examinador
HERR, JENNA FRANCES
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
M. T. (pessoa física)
Representantes
Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutions
Classe 5
pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for the treatment of cancer and tumors; biological and pharmaceutical preparations for cancer and tumor treatment using immunotherapy; therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical products for medical use for the treatment of cancer and tumors; diagnostic preparations for medical purposes, namely, antigens, antibodies, cells for therapeutic use
Classe 40
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacture of therapeutic solutions, namely, antigens, antibodies, T cells
Classe 42
Scientific research services for medical purposes; scientific research and product development, namely, antigen identification, screening and development services; scientific and technological research services in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information with regard to immunotherapy; scientific research and development, namely, providing services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific research, namely, epigenetic antigen screening and identification services for therapeutic research purposes; medical research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; providing medical and scientific research information, namely, designing algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform for use in forecasting the characteristics of antigens and immunological responses through the use of algorithms
Classe 44
providing medical information with regard to immunotherapy
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/02/2024
FIMP
FINAL DISPOSITION PROCESSED
22/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
21/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2023
PUBO
PUBLISHED FOR OPPOSITION
05/09/2023
GPNX
NOTIFICATION PROCESSED BY IB
04/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
16/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2023
RFNP
REFUSAL PROCESSED BY IB
02/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/01/2023
RFRR
REFUSAL PROCESSED BY MPU
08/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/10/2022
CNRT
NON-FINAL ACTION WRITTEN
25/10/2022
DOCK
ASSIGNED TO EXAMINER
21/10/2022
MAFR
APPLICATION FILING RECEIPT MAILED
26/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/07/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MNEMO JETS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.